Loading clinical trials...
Loading clinical trials...
A Phase I/II, Prospective, Open-Label Study to Determine the Safety and Efficacy of CC-4047 in Patients With Primary, Post Polycythemia Vera, or Post Essential Thrombocythemia Myelofibrosis®
Conditions
Interventions
CC-4047
Locations
1
United States
Mayo Clinic
Rochester, Minnesota, United States
Start Date
May 1, 2008
Primary Completion Date
July 7, 2010
Completion Date
December 12, 2019
Last Updated
December 30, 2019
NCT06976918
NCT01137825
NCT04279847
NCT05393674
NCT02370329
NCT02098161
Lead Sponsor
Mayo Clinic
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions